Technical Characteristics Compound name: Epitalon Type: Synthetic peptide Form: Lyophilized powder Purity: 98% Regulatory status: Research Use Only (RUO) Classification: Not intended for clinical, therapeutic, or diagnostic use Each batch undergoes rigorous quality control testing to ensure identity, consistency, and reliability for scientific research applications
Compounded drugs are prepared by a state-licensed compounding pharmacy partner and are permitted under federal law, however, they are not approved by the FDA and do not undergo safety, effectiveness, or manufacturing review
Development of more generalizable score with temporal validation is needed to stratify patients at baseline Disclosure of interest: Authors have nothing to disclose Poster Session II - DIGITAL TRANSFORMATION, AI AND ROBOTICS 07.00 - DIGITAL TRANSFORMATION, AI AND ROBOTICS - 07.01 - TECHNOLOGY INNOVATIONS: ROBOTS, VIRTUAL REALITY, ARTIFICIAL INTELLIGENCE AND MORE P902 - ESOC25-1788 IMPROVING STROKE CARE USING DIGITAL HEALTH TECHNOLOGIES: STROKE SURVIVORS AND CARERS SHARE INSIGHTS ON PATIENT PORTALS Sophie Rowland-Coomber 1 , Zhiqiang Huo 1 , Mahnoor Mustafa 1 , Eleanor Stevens 1 , Timothy Neate 1 , Martin Chapman 1 , Vasa Curcin 1 , Abdel Douiri 1 , Yanzhong Wang 1 , Matthew Dl Oconnell 1 , Charles Wolfe 1 , Iain Marshall 1 , David Wyatt 1 1 King's College London, London, United Kingdom Background and Aims: Digital health technologies (DHTs) can assist stroke survivors and carers in post-stroke management
Neuroimaging 306 , 111178 (2020)
